Study at a glance
What is the difference between free and total vitamin D in blood tests?
This review compares studies of 25-hydroxyvitamin D, the form commonly measured in blood. Most of this substance is attached to proteins, including vitamin D-binding protein. The free amount is not attached to a protein. Total measurements include both attached and free amounts.
How did inherited protein differences affect vitamin D blood results?
A 12-month vitamin D3 trial included 472 people. Two groups with different inherited forms of the binding protein differed by about 30.2% in total 25-hydroxyvitamin D. They differed by only 9.0% in directly measured free 25-hydroxyvitamin D; this smaller difference was not statistically clear. A separate study of 1,057 men found that total and directly measured free amounts were strongly related.
Why does the method used to measure vitamin D-binding protein matter?
One type of binding-protein test suggested large differences linked to the protein forms people inherited and their ancestry. Other methods did not reproduce those differences. Errors in binding-protein measurements can also make calculated free amounts inaccurate. Ancestry cannot reliably substitute for measuring the protein.
Is measuring free vitamin D always better than measuring the total?
In people with liver disease, total amounts were lower while free amounts were similar to those in the comparison group. Rare, severe loss of the binding protein also showed that total measurements can be misleading. These unusual situations do not represent everyone with common inherited differences. The evidence does not establish that free testing is always better; total measurements remain useful.
Read the full article below ↓Vitamin D-binding protein (DBP) affects how total and free 25-hydroxyvitamin D [25(OH)D] relate to one another. Most circulating 25(OH)D is protein-bound, so a change in DBP can alter the size of the measured total pool without causing the same change in the tiny unbound fraction. The complication is that DBP itself can be measured inaccurately in a genotype-dependent way, which means some apparent biological differences are partly analytical. The underlying carrier context is described in Vitamin D Transport Proteins. See Full Study.
Common DBP phenotypes can affect total more than free 25(OH)D
In a 12-month randomised vitamin D3 supplementation study of 472 participants, total 25(OH)D and DBP were lower in the Gc2/Gc2 phenotype than in groups carrying Gc1S. The difference between Gc2/Gc2 and Gc1S/Gc1S was about 30.2% for total 25(OH)D but only about 9.0% for directly measured free 25(OH)D, and the free difference was no longer statistically significant.
This supports the physiological distinction explained in Free vs Total Vitamin D Explained. It does not show that free 25(OH)D should replace total 25(OH)D in every setting. Common inherited differences also need to be interpreted within the broader, non-deterministic context described in Vitamin D Genetics.
Why calculated free vitamin D can inherit DBP measurement error
Calculated free 25(OH)D uses total 25(OH)D, albumin, DBP and assumed binding constants. If the DBP value is biased, the calculated free value is biased too. This became important when a monoclonal DBP assay produced large genotype and ancestry-associated differences that were not reproduced by mass spectrometry or polyclonal methods.
Independent comparisons confirmed that the monoclonal assay recovered common DBP variants differently. The issue is therefore more than laboratory noise: an assay bias can create an apparent physiological explanation when its result is fed into a free-vitamin calculation. This is a direct reason to understand Variability in Vitamin D Measurements and the broader interpretive cautions in Limitations of Vitamin D Blood Tests.
Direct free measurement changed the ancestry interpretation
In a study of 1,057 men from the United States, United Kingdom and The Gambia, total 25(OH)D correlated strongly with directly measured free 25(OH)D. Monoclonal DBP measurements suggested roughly 50% lower DBP in participants of African ancestry, but the large difference disappeared with polyclonal and proteomic methods. The evidence therefore did not support using ancestry as a proxy for DBP biology.
Why the measurement method changes the biological conclusion
The assay studies are important because they use different analytical routes on the same underlying protein question. When a large DBP difference appears with a monoclonal antibody but not with polyclonal antibodies or targeted mass spectrometry, the full difference cannot safely be treated as biological. The analytical method has become part of the explanation.
This distinction matters most when DBP is used to calculate another quantity. A biased protein concentration does not remain an isolated laboratory error; it changes the estimated free or bioavailable vitamin D value and can create an apparently coherent physiological story that is actually method-dependent.
When genuine low DBP can make total and free values diverge
People with liver disease and reduced DBP and albumin had lower total 25(OH)D and a higher percentage free fraction while absolute free 25(OH)D remained comparable with controls. A rare person with homozygous deletion of the GC gene had essentially no DBP and extremely low total vitamin D metabolites while retaining comparatively preserved mineral physiology. These are strong boundary cases showing that the carrier reservoir can materially change what a total value means.
Neither example should be generalised to ordinary common polymorphisms. They show what happens when the binding-protein environment is substantially altered, not what must happen in every person with a lower total 25(OH)D result.
What this evidence supports
- Total and directly measured free 25(OH)D are often strongly related in ordinary populations.
- Changes in DBP concentration can make total and free measures diverge.
- Calculated free 25(OH)D depends on accurate DBP measurement and defensible binding assumptions.
- Genotype-sensitive monoclonal DBP assays can create misleading population differences.
- Free 25(OH)D is not established as universally superior to total 25(OH)D.
- Race or ancestry should not be treated as a biological surrogate for GC genotype or DBP concentration.
The broader interpretive consequence is captured by Vitamin D Status vs Vitamin D Effect: a blood concentration describes one layer of vitamin D physiology, while biological effect depends on additional steps including delivery, uptake, metabolism and tissue response.
In ordinary populations, this does not make total 25(OH)D obsolete. The large multi-cohort study found strong correlation between total and directly measured free 25(OH)D. The value of the free measurement is conditional: it can clarify altered-binding states or research questions in which the unbound fraction itself matters, while total 25(OH)D remains a useful status measure when binding-protein physiology is not severely disrupted.
Primary evidence and publication details
Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. Sollid ST, Hutchinson MYS, Berg V, et al. European Journal of Endocrinology. 2016;174:445-452.
Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry. Hoofnagle AN, Eckfeldt JH, Lutsey PL. New England Journal of Medicine. 2015;373:1480-1482.
Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes. Denburg MR, Hoofnagle AN, Sayed S, et al. Journal of Bone and Mineral Research. 2016;31:1128-1136.
Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations. Schwartz JB, et al. Journal of Clinical Endocrinology and Metabolism. 2016;101:2226-2234.
Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG. Journal of Clinical Investigation. 1986;78:748-752.
Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene. Henderson CM, Fink SL, Bassyouni H, et al. New England Journal of Medicine. 2019;380:1150-1157.
Related reading
Bipolar disorder in youth is associated with increased levels of vitamin D-binding protein
We quantified DBP levels in participants by western blot.
Original paper ↗Read more →Clinical utility of cerebrospinal fluid vitamin D-binding protein as a novel biomarker for the diagnosis of viral and bacterial CNS infections
VDBP levels were analyzed and compared by CNS infection, pathogen, CSF opening pressure, and GC genotype.
Original paper ↗Read more →Confirmation and Identification of Biomarkers Implicating Environmental Triggers in the Pathogenesis of Type 1 Diabetes
Female T1D subjects were notably elevated in CRP levels compared to control, while males were similar.
Original paper ↗Read more →Deconvoluting the Biological Roles of Vitamin D-Binding Protein During Pregnancy: A Both Clinical and Theoretical Challenge
The teleological purpose of an ongoing pregnancy is to fulfill its fundamental role of a successful, uncomplicated delivery, in conjunction with an optimal intrauterine environment for the developing fetus.
Original paper ↗Read more →Detailed investigations of proximal tubular function in Imerslund-Gräsbeck syndrome
The aim of this study was to characterise novel disease-causing mutations and correlate novel and previously reported mutations with the presence of low-molecular-weight proteinuria.
Original paper ↗Read more →Development of free 25-hydroxyvitamin D3 assay method using liquid chromatography-tandem mass spectrometry
The free hormone hypothesis has triggered controversies regarding the measurement of free vitamin D metabolites, such as free 25-hydroxyvitamin D (25(OH)D), as a suitable indicator for total vitamin D for clinical use.
Original paper ↗Read more →Is Vitamin D Binding Protein a Novel Predictor of Labour?
VDBP measured in-labour was significantly increased 4.2 to 7.4-fold compared to 4 to 7, 8 to 14 and 15 to 28 days before labour (P.
Original paper ↗Read more →Maternal and Neonatal Vitamin D Binding Protein Polymorphisms and 25-Hydroxyvitamin D Cutoffs as Determinants of Neonatal Birth Anthropometry
Our aim was to assess the combined effect of maternal and neonatal VDBP polymorphism heterogeneity in conjunction with different maternal and neonatal 25(OH)D cutoffs on the neonatal anthropometric profile at birth.
Original paper ↗Read more →Microglia‐Derived Vitamin D Binding Protein Mediates Synaptic Damage and Induces Depression by Binding to the Neuronal Receptor Megalin
Vitamin D binding protein (VDBP) is a potential biomarker of major depressive disorder (MDD).
Original paper ↗Read more →Serum protein changes in a rat model of chronic pain show a correlation between animal and humans
In previous works we showed the overexpression of some proteins in biological fluids from patients suffering chronic pain.
Original paper ↗Read more →The association of vitamin D binding protein levels and genotypes with type 1 diabetes in the black South African population
Therefore, this study aimed to determine whether rs4588, rs7041 or serum VDBP levels were associated with T1D in this population.
Original paper ↗Read more →Urinary Prognostic Biomarkers and Classification of IgA Nephropathy by High Resolution Mass Spectrometry Coupled with Liquid Chromatography
Our aim was to test urine proteomics as a non-invasive method for classification of IgA nephropathy.
Original paper ↗Read more →Diurnal rhythms of vitamin D binding protein and total and free vitamin D metabolites
The free 1,25(OH)2D DR was attenuated compared to that of total 1,25(OH)2D.
Original paper ↗Read more →Polymorphisms of the Vitamin D Binding Protein (VDBP) and Free Vitamin D in Patients with Cystic Fibrosis
Objectives/Background: Vitamin D-binding protein (VDBP) and free vitamin D are new markers that are being studied as a possible markers of vitamin D status.
Original paper ↗Read more →The Role of Vitamin D Binding Protein, Total and Free 25-Hydroxyvitamin D in Diabetes
Vitamin D is important for bone health, but may also have extra-skeletal effects.
Original paper ↗Read more →Vitamin D-Binding Protein, Bioavailable, and Free 25(OH)D, and Mortality: A Systematic Review and Meta-Analysis
Introduction: Observational studies reported inverse associations between serum total 25-hydroxyvitamin D (25(OH)D) concentrations and mortality.
Original paper ↗Read more →Impact of DBP variability on free vs total vitamin D: Full Study
Full Study of how DBP variability affects free and total vitamin D, including genotype, assay bias, binding assumptions and altered binding-protein states.
Read more →DBP Variability and Free vs Total Vitamin D: Evidence Synthesis
Explore how DBP variability, genotype and measurement methods affect total and free vitamin D, and why assay choice matters when interpreting results.
Read more →The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases
Vitamin D (calciferol) is a fat-soluble vitamin that has a significant role in phospho-calcium metabolism, maintaining normal calcium levels and bone health development.
Original paper ↗Read more →Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein
Serum 25-hydroxyvitamin D [25(OH)D] is often deficient (.
Original paper ↗Read more →Vitamin D Binding Protein Genotype Is Associated with Serum 25-Hydroxyvitamin D and PTH Concentrations, as Well as Bone Health in Children and Adolescents in Finland
We examined the role of GC genotypes in S-25(OH)D status and BMD in 231 Finnish children and adolescents aged 7−19 yr.
Original paper ↗Read more →Original sources
Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D
Published in Sollid ST, Hutchinson MYS, Berg V, et al. European Journal of Endocrinology (2016).
Publication details
Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. Sollid ST, Hutchinson MYS, Berg V, et al. European Journal of Endocrinology. 2016;174:445-452.
Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry
Published in Hoofnagle AN, Eckfeldt JH, Lutsey PL. New England Journal of Medicine (2015).
Publication details
Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry. Hoofnagle AN, Eckfeldt JH, Lutsey PL. New England Journal of Medicine. 2015;373:1480-1482.
Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes
Published in Denburg MR, Hoofnagle AN, Sayed S, et al. Journal of Bone and Mineral Research (2016).
Publication details
Comparison of Two ELISA Methods and Mass Spectrometry for Measurement of Vitamin D-Binding Protein: Implications for the Assessment of Bioavailable Vitamin D Concentrations Across Genotypes. Denburg MR, Hoofnagle AN, Sayed S, et al. Journal of Bone and Mineral Research. 2016;31:1128-1136.
Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations
Published in Schwartz JB, et al. Journal of Clinical Endocrinology and Metabolism (2016).
Publication details
Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations. Schwartz JB, et al. Journal of Clinical Endocrinology and Metabolism. 2016;101:2226-2234.
Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels
Published in Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG. Journal of Clinical Investigation (1986).
Publication details
Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG. Journal of Clinical Investigation. 1986;78:748-752.
Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene
Published in Henderson CM, Fink SL, Bassyouni H, et al. New England Journal of Medicine (2019).
Publication details
Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene. Henderson CM, Fink SL, Bassyouni H, et al. New England Journal of Medicine. 2019;380:1150-1157.